<?xml version="1.0" encoding="UTF-8"?>
<p id="par0095">PD-L1 inhibitors could improve control of chronic viral infections, through the depletion and exhaustion of T cells. Blocking the PD-1/PD-L1 axis restored the immune functions of exhausted CD8 + T cells, thereby improving the virus clearance in mice chronically infected with lymphocytic choriomeningitis virus (LCMV) (
 <xref rid="bib0010" ref-type="bibr">Barber et al., 2006</xref>). Preliminary results suggested that treatment with anti-PD1 might improve the outcomes of patients with progressive multifocal leukoencephalopathy due to the JC virus (
 <xref rid="bib0140" ref-type="bibr">Koralnik, 2019</xref>). However, this benefit was observed only in patients with JC virus-specific CD4 + T cells, showing features of exhausted lymphocytes.
</p>
